about
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy.Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.Nitric Oxide Donor Molsidomine Positively Modulates Myogenic Differentiation of Embryonic Endothelial Progenitors.Hematopoietic Reprogramming In Vitro Informs In Vivo Identification of Hemogenic Precursors to Definitive Hematopoietic Stem Cells.Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitorsA short history of hemogenic endothelium.Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas.Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration.Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells.Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors.Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo.Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cellsKit ligand has a critical role in mouse yolk sac and aorta-gonad-mesonephros hematopoiesis
P50
Q34124872-C67D519A-BABA-49F0-A60D-B6D4A6107BD5Q35100498-D3BA20A2-D56C-4D92-B067-362459245E3DQ36043923-0C080FF7-6FAA-48BC-9D56-20069D568864Q36168025-E8558D4F-976E-44AD-A4B1-7CF077A8C1B8Q36672149-21D3BFC9-F707-4018-9A18-F44C011273F4Q37519602-15D302F5-1DA6-40B8-8CA9-27CC554604A2Q38149502-2C58554C-13CC-4434-92FC-76B7BEF2E3E7Q40128408-A9CFE89B-D4A0-4A3B-8B4A-1492E10649E3Q40138821-6E3E13AB-D8E6-4BC6-A3CB-8B0473CBA0D4Q45856689-54D1CD6A-C809-4847-87E3-BEA3959945C4Q48425484-70BF74F1-D113-4FDE-B194-D8A0CA319A8DQ50668574-27BF2F28-FD32-40F6-85F0-17BBA47E51FBQ64008549-DE9D3557-CD65-4E28-A2D0-5F727F44B85CQ91238484-70FED2B6-6E4E-4BB8-A9FE-D9B182FBC290
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emanuele Azzoni
@ast
Emanuele Azzoni
@en
Emanuele Azzoni
@es
Emanuele Azzoni
@nl
Emanuele Azzoni
@sl
type
label
Emanuele Azzoni
@ast
Emanuele Azzoni
@en
Emanuele Azzoni
@es
Emanuele Azzoni
@nl
Emanuele Azzoni
@sl
prefLabel
Emanuele Azzoni
@ast
Emanuele Azzoni
@en
Emanuele Azzoni
@es
Emanuele Azzoni
@nl
Emanuele Azzoni
@sl
P106
P21
P31
P496
0000-0002-4572-5692
P569
2000-01-01T00:00:00Z